Cytochroma Inc.
Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).
Investment year: 2002
Industry sector: Biotechnology
Region: Ontario
Fund:
Healthcare Venture Fund
Follow Cytochroma Inc.
BDC Venture Capital Partner
